NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

UPDATE 2-FTSE 100 ekes out gains on pharma strength

Published 28/10/2019, 18:47
© Reuters.  UPDATE 2-FTSE 100 ekes out gains on pharma strength
UK100
-
HSBA
-
CNE
-
FTMC
-
FTNMX301010
-
AML
-

* FTSE 100 up 0.1%, FTSE 250 up 0.5%
* Astra, GSK offer most support to main bourse
* HSBC falls after profit miss
* Cairn Energy biggest midcap faller

(Adds company news items, changes analyst quote, updates share
moves)
By Muvija M and Shashwat Awasthi
Oct 28 (Reuters) - The exporter-laden FTSE 100 .FTSE
recovered from early losses on Monday despite a rebound in
sterling, boosted by gains in leading drug stocks and as
prospects for a U.S.-China trade agreement powered miners and
industrials.
The blue chip index closed 0.1% higher, lagging peers on
Wall Street and in Europe as a near 4% drop in HSBC HSBA.L
after an underwhelming earnings update, and a slide in dollar
earners, capped gains.
The more domestically-focused FTSE 250 .FTMC outperformed
with a 0.5% rise ahead of a parliamentary vote on Prime Minister
Boris Johnson's demand for a general election.
AstraZeneca AZN.L climbed as much 3.6% after saying a
combination of its cancer drug, Imfinzi, along with chemotherapy
helped curb progression of lung cancer in a late-stage study.
The shares ended up 1%. In the same sector GlaxoSmithKline GSK.L added 2.2% after
the company said it had begun a late-stage study of its
experimental antibiotic in patients with urinary tract
infections and gonorrhoea. Gains of between 1.3% and 2.2% in Glencore GLEN.L , BHP
BHPB.L and Anglo American AAL.L powered the mining sector
.FTNMX1770 , exposed to the international trade scenario, to a
one-month high after U.S. President Donald Trump said he
expected to sign a significant part of a trade deal with China
ahead of schedule. TARGET
By contrast HSBC shares HSBA.L suffered their biggest
one-day loss in eight months as the bank's third-quarter profit
missed expectations and it dropped its 2020 earnings target amid
macro-economic uncertainties. The update dragged a sub-index of banks .FTNMX8350 2.4%
lower.
Financial companies have also had to adjust to a lower
interest rate environment this year as central banks globally
move to loosen monetary policies to cushion an impact from trade
tensions.
To that end, markets are also keeping a close eye on the
U.S. Federal Reserve's meeting this week for more support to the
slowing global economy.
"We see the Fed cutting rates this week and possibly again
next year, as it seeks to provide insurance against a broad
economic slowdown", BlackRock analysts wrote in their weekly
note.
In addition, UK firms face a lack of clarity at home as
lawmakers and Prime Minister Boris Johnson feud over Brexit.
Earlier in the day, the European Union agreed a three-month
flexible delay to the Oct. 31 exit date. Among midcaps, there was an 8.1% plunge in Cairn Energy
CNE.L after the oil and gas explorer abandoned an offshore
well in Mexico.
Aston Martin AML.L , which has plunged nearly 80% from its
2018 debut, dropped 8.5% after Bank of America Merrill Lynch
downgraded the stock.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.